Tonix Pharmaceuticals Holding (TNXP) Convertible Debt (2011)
Tonix Pharmaceuticals Holding (TNXP) posted Convertible Debt of $2.1 million for Q4 2011.
Analysis
Tonix Pharmaceuticals Holding (TNXP) Convertible Debt (2011) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Convertible Debt for 1 years, with the latest figure at $2.1 million in Q4 2011.
- On a quarterly basis, Convertible Debt changed N/A year-over-year to $2.1 million in Q4 2011; TTM through Dec 2011 was $2.1 million, a N/A change from a year earlier, with the FY2011 full-year figure at $2.1 million, changed N/A from the prior year.
- Convertible Debt was $2.1 million for Q4 2011 at Tonix Pharmaceuticals Holding.
- The five-year high for Convertible Debt was $2.1 million in Q4 2011, with the low at $2.1 million in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn |